Cisco
CSCO
NVIDIA
NVDA
Taiwan Semiconductor
TSM
ASML Holding
ASML
Apple
AAPL
US Stock MarketDetailed Quotes
INCY Incyte
- 60.620
- -0.060-0.10%
Trading Mar 28 12:10 ET
11.73BMarket Cap404.13P/E (TTM)
60.970High60.350Low194.84KVolume60.720Open60.680Pre Close11.81MTurnover0.12%Turnover Ratio404.13P/E (Static)193.52MShares83.95052wk High3.40P/B9.78BFloat Cap50.35052wk Low--Dividend TTM161.34MShs Float153.150Historical High--Div YieldTTM1.02%Amplitude1.850Historical Low60.628Avg Price1Lot Size
About Incyte Company
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Company Profile
SymbolINCY
Company NameIncyte
Listing DateNov 4, 1993
Issue Price7.50
Founded1991
CEOMr. Herve Hoppenot
MarketNASDAQ
Employees2617
Fiscal Year Ends12-31
Address1801 Augustine Cut-Off
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19803
Phone1-302-498-6700
Websitehttp://www.incyte.com
Company Executives
- Name
- Position
- Salary
- Herve Hoppenot
- Chairman of the Board, President and Chief Executive Officer
- 16.66M
- Christiana Stamoulis, M.B.A.
- Executive Vice President and Chief Financial Officer
- 5.08M
- Thomas Tray
- Vice President and Chief Accounting Officer
- --
- Dr. Steven H. Stein, M.D.
- Executive Vice President and Chief Medical Officer
- 5.63M
- Barry P. Flannelly, Pharm.D.
- Executive Vice President and General Manager, North America
- 4.09M
- Matteo Trotta
- Executive Vice President and General Manager, Dermatology US
- --
- Sheila A Denton
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Paula J. Swain
- Executive Vice President, Human Resources
- --
- Vijay K. Iyengar
- Executive Vice President, Global Strategy and Corporate Development
- --
- Mohamed Khairie Issa
- Executive Vice President and Head of US Oncology
- --
- Michael James Morrissey
- Executive Vice President and Head of Global Technical Operations
- --
- Lee Heeson
- Executive Vice President, Incyte International
- --
- Dr. Pablo J. Cagnoni, M.D.
- President and Head of Research and Development
- 15.83M
- Paul J. Clancy
- Independent Director
- 479.76K
- Julian C. Baker
- Lead Independent Director
- 512.76K
- Jean-Jacques Bienaime
- Independent Director
- 478.76K
- Dr. Susanne Schaffert, PhD
- Independent Director
- 444.76K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 454.76K
- Dr. Katherine A. High, M.D.
- Independent Director
- 454.76K
- Dr. Jacqualyn A. Fouse, PhD
- Independent Director
- 466.26K
- Dr. Edmund P. Harrigan, M.D.
- Independent Director
- 482.26K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
